{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T17:17:09Z","timestamp":1774027029897,"version":"3.50.1"},"reference-count":80,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T00:00:00Z","timestamp":1732320000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"NCI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","award":["P50CA116201"],"award-info":[{"award-number":["P50CA116201"]}],"id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","award":["R01CA251801"],"award-info":[{"award-number":["R01CA251801"]}],"id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005968","name":"Leukemia Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Neoplasia"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.bneo.2024.100059","type":"journal-article","created":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T18:09:11Z","timestamp":1732558151000},"page":"100059","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Aberrant heterochromatin silences immune response genes in chronic lymphocytic leukemia"],"prefix":"10.1016","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-3709-3345","authenticated-orcid":false,"given":"Olivia M.","family":"Depies","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4968-7782","authenticated-orcid":false,"given":"Qianqian","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sutapa","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8336-0410","authenticated-orcid":false,"given":"Zhenqing","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4842-4833","authenticated-orcid":false,"given":"Weiguo","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7313-1875","authenticated-orcid":false,"given":"Kari G.","family":"Rabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingma S.","family":"Hoel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather C.","family":"Darby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1885-7224","authenticated-orcid":false,"given":"Chuanhe","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3860-4830","authenticated-orcid":false,"given":"Esteban","family":"Braggio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3221-7314","authenticated-orcid":false,"given":"Sameer A.","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5173-4712","authenticated-orcid":false,"given":"Susan L.","family":"Slager","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5951-5055","authenticated-orcid":false,"given":"Neil E.","family":"Kay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8243-7251","authenticated-orcid":false,"given":"Zhiquan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.bneo.2024.100059_bib1","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/nbt1010-1033","article-title":"Linking cell signaling and the epigenetic machinery","volume":"28","author":"Mohammad","year":"2010","journal-title":"Nat Biotechnol"},{"issue":"10","key":"10.1016\/j.bneo.2024.100059_bib2","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/iub.557","article-title":"Signaling epigenetics: novel insights on cell signaling and epigenetic regulation","volume":"63","author":"Arzate-Mej\u00eda","year":"2011","journal-title":"IUBMB Life"},{"issue":"6348","key":"10.1016\/j.bneo.2024.100059_bib3","doi-asserted-by":"crossref","DOI":"10.1126\/science.aal2380","article-title":"Epigenetic plasticity and the hallmarks of cancer","volume":"357","author":"Flavahan","year":"2017","journal-title":"Science"},{"issue":"6413","key":"10.1016\/j.bneo.2024.100059_bib4","doi-asserted-by":"crossref","first-page":"eaav1898","DOI":"10.1126\/science.aav1898","article-title":"The chromatin accessibility landscape of primary human cancers","volume":"362","author":"Corces","year":"2018","journal-title":"Science"},{"issue":"6278","key":"10.1016\/j.bneo.2024.100059_bib5","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1126\/science.aad5944","article-title":"Disordered methionine metabolism in MTAP\/CDKN2A-deleted cancers leads to dependence on PRMT5","volume":"351","author":"Mavrakis","year":"2016","journal-title":"Science"},{"issue":"6331","key":"10.1016\/j.bneo.2024.100059_bib6","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1126\/science.aah6893","article-title":"PI3K pathway regulates ER-dependent transcription in breast cancer through the epigenetic regulator KMT2D","volume":"355","author":"Toska","year":"2017","journal-title":"Science"},{"issue":"6559","key":"10.1016\/j.bneo.2024.100059_bib7","doi-asserted-by":"crossref","DOI":"10.1126\/science.abc1048","article-title":"Developmental chromatin programs determine oncogenic competence in melanoma","volume":"373","author":"Baggiolini","year":"2021","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.bneo.2024.100059_bib8","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jncc.2020.12.003","article-title":"Chromatin assembly factor 1 suppresses epigenetic reprogramming toward adaptive drug resistance","volume":"1","author":"Wang","year":"2021","journal-title":"Journal of the National Cancer Center"},{"issue":"7","key":"10.1016\/j.bneo.2024.100059_bib9","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/s41568-021-00357-x","article-title":"The language of chromatin modification in human cancers","volume":"21","author":"Zhao","year":"2021","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"10.1016\/j.bneo.2024.100059_bib10","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1182\/blood-2015-02-585042","article-title":"Genomic and epigenomic heterogeneity in chronic lymphocytic leukemia","volume":"126","author":"Guieze","year":"2015","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.bneo.2024.100059_bib11","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/s41571-019-0239-8","article-title":"Chronic lymphocytic leukaemia: from genetics to treatment","volume":"16","author":"Bosch","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"issue":"11","key":"10.1016\/j.bneo.2024.100059_bib12","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/ng.2443","article-title":"Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia","volume":"44","author":"Kulis","year":"2012","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.bneo.2024.100059_bib13","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.ccell.2014.10.012","article-title":"Locally disordered methylation forms the basis of intratumor methylome variation in chronic lymphocytic leukemia","volume":"26","author":"Landau","year":"2014","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.bneo.2024.100059_bib14","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/s41591-018-0028-4","article-title":"The reference epigenome and regulatory chromatin landscape of chronic lymphocytic leukemia","volume":"24","author":"Beekman","year":"2018","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.bneo.2024.100059_bib15","doi-asserted-by":"crossref","DOI":"10.15252\/msb.20188339","article-title":"Linking aberrant chromatin features in chronic lymphocytic leukemia to transcription factor networks","volume":"15","author":"Mallm","year":"2019","journal-title":"Mol Syst Biol"},{"issue":"7","key":"10.1016\/j.bneo.2024.100059_bib16","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41408-022-00690-w","article-title":"B\u00a0cell receptor signaling drives APOBEC3 expression via direct enhancer regulation in chronic lymphocytic leukemia B cells","volume":"12","author":"Wang","year":"2022","journal-title":"Blood Cancer J"},{"issue":"1","key":"10.1016\/j.bneo.2024.100059_bib17","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1038\/s41467-019-09982-5","article-title":"CUT&Tag for efficient epigenomic profiling of small samples and single cells","volume":"10","author":"Kaya-Okur","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.bneo.2024.100059_bib18","series-title":"Bench top CUT&Tag","author":"Steven","year":"2020"},{"key":"10.1016\/j.bneo.2024.100059_bib19","series-title":"CUT&Tag Data Processing and Analysis Tutorial","author":"Ye","year":"2020"},{"issue":"4","key":"10.1016\/j.bneo.2024.100059_bib20","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.1923","article-title":"Fast gapped-read alignment with Bowtie 2","volume":"9","author":"Langmead","year":"2012","journal-title":"Nat Methods"},{"issue":"1","key":"10.1016\/j.bneo.2024.100059_bib21","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13072-019-0287-4","article-title":"Peak calling by sparse enrichment analysis for CUT&RUN chromatin profiling","volume":"12","author":"Meers","year":"2019","journal-title":"Epigenet Chromatin"},{"issue":"W1","key":"10.1016\/j.bneo.2024.100059_bib22","doi-asserted-by":"crossref","first-page":"W160","DOI":"10.1093\/nar\/gkw257","article-title":"deepTools2: a next generation web server for deep-sequencing data analysis","volume":"44","author":"Ramirez","year":"2016","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"10.1016\/j.bneo.2024.100059_bib23","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nbt.1630","article-title":"GREAT improves functional interpretation of cis-regulatory regions","volume":"28","author":"McLean","year":"2010","journal-title":"Nat Biotechnol"},{"issue":"12","key":"10.1016\/j.bneo.2024.100059_bib24","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"issue":"5","key":"10.1016\/j.bneo.2024.100059_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21051825","article-title":"Immune response dysfunction in chronic lymphocytic leukemia: dissecting molecular mechanisms and microenvironmental conditions","volume":"21","author":"Arruga","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.bneo.2024.100059_bib26","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/cr.2011.22","article-title":"Regulation of chromatin by histone modifications","volume":"21","author":"Bannister","year":"2011","journal-title":"Cell Res"},{"issue":"5","key":"10.1016\/j.bneo.2024.100059_bib27","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.molcel.2013.01.038","article-title":"Modification of enhancer chromatin: what, how, and why?","volume":"49","author":"Calo","year":"2013","journal-title":"Mol Cell"},{"issue":"20","key":"10.1016\/j.bneo.2024.100059_bib28","doi-asserted-by":"crossref","first-page":"11458","DOI":"10.1073\/pnas.96.20.11458","article-title":"Novel neurotrophin-1\/B cell-stimulating factor-3: a cytokine of the IL-6 family","volume":"96","author":"Senaldi","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bneo.2024.100059_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.621931","article-title":"Interleukin-1 as innate mediator of T cell immunity","volume":"11","author":"Van Den Eeckhout","year":"2021","journal-title":"Front Immunol"},{"issue":"17","key":"10.1016\/j.bneo.2024.100059_bib30","doi-asserted-by":"crossref","first-page":"7119","DOI":"10.1073\/pnas.0902745106","article-title":"IL-1 acts directly on CD4\u00a0T cells to enhance their antigen-driven expansion and differentiation","volume":"106","author":"Ben-Sasson","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"10.1016\/j.bneo.2024.100059_bib31","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1084\/jem.20122006","article-title":"IL-1 enhances expansion, effector function, tissue localization, and memory response of antigen-specific CD8\u00a0T cells","volume":"210","author":"Ben-Sasson","year":"2013","journal-title":"J\u00a0Exp Med"},{"issue":"1","key":"10.1016\/j.bneo.2024.100059_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molcel.2007.09.011","article-title":"Facultative heterochromatin: is there a distinctive molecular signature?","volume":"28","author":"Trojer","year":"2007","journal-title":"Mol Cell"},{"issue":"1","key":"10.1016\/j.bneo.2024.100059_bib33","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1038\/s41467-019-09645-5","article-title":"Corrupted coordination of epigenetic modifications leads to diverging chromatin states and transcriptional heterogeneity in CLL","volume":"10","author":"Pastore","year":"2019","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.bneo.2024.100059_bib34","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1182\/blood-2010-07-155663","article-title":"Cellular origin(s) of chronic lymphocytic leukemia: cautionary notes and additional considerations and possibilities","volume":"117","author":"Chiorazzi","year":"2011","journal-title":"Blood"},{"issue":"6424","key":"10.1016\/j.bneo.2024.100059_bib35","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1126\/science.aau0583","article-title":"H3K9me3-heterochromatin loss at protein-coding genes enables developmental lineage specification","volume":"363","author":"Nicetto","year":"2019","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.bneo.2024.100059_bib36","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/ng.3753","article-title":"Epigenomic reprogramming during pancreatic cancer progression links anabolic glucose metabolism to distant metastasis","volume":"49","author":"McDonald","year":"2017","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.bneo.2024.100059_bib37","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.molcel.2012.05.011","article-title":"Cell-type-specific control of enhancer activity by H3K9 trimethylation","volume":"46","author":"Zhu","year":"2012","journal-title":"Mol Cell"},{"issue":"4","key":"10.1016\/j.bneo.2024.100059_bib38","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.molcel.2021.12.037","article-title":"SETDB1\/NSD-dependent H3K9me3\/H3K36me3 dual heterochromatin maintains gene expression profiles by bookmarking poised enhancers","volume":"82","author":"Barral","year":"2022","journal-title":"Mol Cell"},{"issue":"7354","key":"10.1016\/j.bneo.2024.100059_bib39","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature10113","article-title":"Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia","volume":"475","author":"Puente","year":"2011","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bneo.2024.100059_bib40","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1158\/2643-3230.BCD-19-0058","article-title":"Preneoplastic alterations define CLL DNA methylome and persist through disease progression and therapy","volume":"2","author":"Kretzmer","year":"2021","journal-title":"Blood Cancer Discovery"},{"issue":"8","key":"10.1016\/j.bneo.2024.100059_bib41","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/ni.2641","article-title":"Transcription factor EBF1 is essential for the maintenance of B cell identity and prevention of alternative fates in committed cells","volume":"14","author":"Nechanitzky","year":"2013","journal-title":"Nat Immunol"},{"issue":"3","key":"10.1016\/j.bneo.2024.100059_bib42","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/ng.3488","article-title":"DNA methylation dynamics during B cell maturation underlie a continuum of disease phenotypes in chronic lymphocytic leukemia","volume":"48","author":"Oakes","year":"2016","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.bneo.2024.100059_bib43","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/s41467-020-20849-y","article-title":"Dynamics of genome architecture and chromatin function during human B cell differentiation and neoplastic transformation","volume":"12","author":"Vilarrasa-Blasi","year":"2021","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.bneo.2024.100059_bib44","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0145-2126(98)00154-4","article-title":"MEC1 and MEC2: two new cell lines derived from B-chronic lymphocytic leukaemia in prolymphocytoid transformation","volume":"23","author":"Stacchini","year":"1999","journal-title":"Leuk Res"},{"issue":"12","key":"10.1016\/j.bneo.2024.100059_bib45","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1182\/blood-2013-09-527853","article-title":"Prolonged lymphocytosis during ibrutinib therapy is associated with distinct molecular characteristics and does not indicate a suboptimal response to therapy","volume":"123","author":"Woyach","year":"2014","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.bneo.2024.100059_bib46","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41467-019-14081-6","article-title":"Chromatin mapping and single-cell immune profiling define the temporal dynamics of ibrutinib response in CLL","volume":"11","author":"Rendeiro","year":"2020","journal-title":"Nat Commun"},{"issue":"S2","key":"10.1016\/j.bneo.2024.100059_bib47","doi-asserted-by":"crossref","DOI":"10.1002\/hon.29_2879","article-title":"Adaptation of chronic lymphocytic leukemia to ibrutinib is mediated by epigenetic plasticity of residual disease and by-pass signaling via MAPK pathway","volume":"39","author":"Terzi di Bergamo","year":"2021","journal-title":"Hematol Oncol"},{"issue":"1","key":"10.1016\/j.bneo.2024.100059_bib49","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov"},{"issue":"8","key":"10.1016\/j.bneo.2024.100059_bib50","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/nrc.2016.62","article-title":"The role of enhancers in cancer","volume":"16","author":"Sur","year":"2016","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"10.1016\/j.bneo.2024.100059_bib51","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.ccell.2018.11.001","article-title":"Enhancer architecture and essential core regulatory circuitry of chronic lymphocytic leukemia","volume":"34","author":"Ott","year":"2018","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.bneo.2024.100059_bib52","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14175","article-title":"Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia","volume":"8","author":"Law","year":"2017","journal-title":"Nat Commun"},{"issue":"10","key":"10.1016\/j.bneo.2024.100059_bib53","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1182\/blood.2020006965","article-title":"Outcomes of COVID-19 in patients with CLL: a multicenter international experience","volume":"136","author":"Mato","year":"2020","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.bneo.2024.100059_bib54","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/(SICI)1096-8652(199905)61:1<46::AID-AJH9>3.0.CO;2-G","article-title":"Expression of regeneration and tolerance factor on B cell chronic lymphocytic leukemias: a possible mechanism for escaping immune surveillance","volume":"61","author":"Aslakson","year":"1999","journal-title":"Am J Hematol"},{"issue":"9","key":"10.1016\/j.bneo.2024.100059_bib55","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/nm0997-984","article-title":"Acquired CD40-ligand deficiency in chronic lymphocytic leukemia","volume":"3","author":"Cantwell","year":"1997","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.bneo.2024.100059_bib56","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1002\/cncr.22094","article-title":"The effect of immunoglobulin VH gene mutation status and other prognostic factors on the incidence of major infections in patients with chronic lymphocytic leukemia","volume":"107","author":"Francis","year":"2006","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.bneo.2024.100059_bib57","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1006\/clim.1998.4617","article-title":"Heterogeneity of serum IgG subclass deficiencies in B chronic lymphocytic leukemia","volume":"90","author":"Lacombe","year":"1999","journal-title":"Clin Immunol"},{"key":"10.1016\/j.bneo.2024.100059_bib58","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1182\/asheducation-2007.1.332","article-title":"Management of infectious complications in patients with chronic lymphocytic leukemia","author":"Morrison","year":"2007","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"2","key":"10.1016\/j.bneo.2024.100059_bib59","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1053\/j.seminoncol.2005.12.013","article-title":"Infectious complications of chronic lymphocytic leukemia","volume":"33","author":"Wadhwa","year":"2006","journal-title":"Semin Oncol"},{"issue":"5","key":"10.1016\/j.bneo.2024.100059_bib60","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.4049\/jimmunol.181.5.3364","article-title":"EBF1 is essential for B-lineage priming and establishment of a transcription factor network in common lymphoid progenitors","volume":"181","author":"Zandi","year":"2008","journal-title":"J\u00a0Immunol"},{"issue":"6","key":"10.1016\/j.bneo.2024.100059_bib61","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1084\/jem.20101947","article-title":"Ebf1 or Pax5 haploinsufficiency synergizes with STAT5 activation to initiate acute lymphoblastic leukemia","volume":"208","author":"Heltemes-Harris","year":"2011","journal-title":"J\u00a0Exp Med"},{"issue":"26","key":"10.1016\/j.bneo.2024.100059_bib62","doi-asserted-by":"crossref","first-page":"3969","DOI":"10.1182\/blood-2015-05-639427","article-title":"Ebf1 in DNA repair and leukemogenesis","volume":"125","author":"Georgopoulos","year":"2015","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.bneo.2024.100059_bib63","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1128\/MCB.19.1.392","article-title":"The B29 (immunoglobulin beta-chain) gene is a genetic target for early B-cell factor","volume":"19","author":"Akerblad","year":"1999","journal-title":"Mol Cell Biol"},{"issue":"1","key":"10.1016\/j.bneo.2024.100059_bib64","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1074-7613(00)80507-5","article-title":"EBF and E47 collaborate to induce expression of the endogenous immunoglobulin surrogate light chain genes","volume":"7","author":"Sigvardsson","year":"1997","journal-title":"Immunity"},{"issue":"17","key":"10.1016\/j.bneo.2024.100059_bib65","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1002\/cncr.29438","article-title":"Hypogammaglobulinemia in newly diagnosed chronic lymphocytic leukemia: natural history, clinical correlates, and outcomes","volume":"121","author":"Parikh","year":"2015","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.bneo.2024.100059_bib66","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1084\/jem.20081571","article-title":"The induction of antibody production by IL-6 is indirectly mediated by IL-21 produced by CD4+ T cells","volume":"206","author":"Dienz","year":"2009","journal-title":"J\u00a0Exp Med"},{"issue":"9","key":"10.1016\/j.bneo.2024.100059_bib67","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1182\/blood-2012-09-457531","article-title":"T\u00a0cells from CLL patients exhibit features of T-cell exhaustion but retain capacity for cytokine production","volume":"121","author":"Riches","year":"2013","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.bneo.2024.100059_bib68","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1038\/s41375-020-0873-2","article-title":"T-cells in chronic lymphocytic leukemia: guardians or drivers of disease?","volume":"34","author":"Roessner","year":"2020","journal-title":"Leukemia"},{"issue":"7","key":"10.1016\/j.bneo.2024.100059_bib69","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.vaccine.2021.01.001","article-title":"The humoral immune response to high-dose influenza vaccine in persons with monoclonal B-cell lymphocytosis (MBL) and chronic lymphocytic leukemia (CLL)","volume":"39","author":"Whitaker","year":"2021","journal-title":"Vaccine"},{"issue":"26","key":"10.1016\/j.bneo.2024.100059_bib70","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1200\/JCO.22.00088","article-title":"Humoral responses against SARS-CoV-2 and variants of concern after mRNA vaccines in patients with non-Hodgkin lymphoma and chronic lymphocytic leukemia","volume":"40","author":"Chang","year":"2022","journal-title":"J\u00a0Clin Oncol"},{"issue":"7","key":"10.1016\/j.bneo.2024.100059_bib71","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1016\/j.celrep.2018.07.041","article-title":"Enhancer activity requires CBP\/P300 bromodomain-dependent histone H3K27 acetylation","volume":"24","author":"Raisner","year":"2018","journal-title":"Cell Rep"},{"issue":"50","key":"10.1016\/j.bneo.2024.100059_bib72","doi-asserted-by":"crossref","first-page":"21931","DOI":"10.1073\/pnas.1016071107","article-title":"Histone H3K27ac separates active from poised enhancers and predicts developmental state","volume":"107","author":"Creyghton","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"10.1016\/j.bneo.2024.100059_bib73","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1016\/j.molcel.2021.04.015","article-title":"Targeting histone acetylation dynamics and oncogenic transcription by catalytic P300\/CBP inhibition","volume":"81","author":"Hogg","year":"2021","journal-title":"Mol Cell"},{"issue":"9","key":"10.1016\/j.bneo.2024.100059_bib74","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1038\/s41416-021-01321-0","article-title":"Achieving clinical success with BET inhibitors as anti-cancer agents","volume":"124","author":"Shorstova","year":"2021","journal-title":"Br J Cancer"},{"issue":"6","key":"10.1016\/j.bneo.2024.100059_bib75","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/s41588-022-01091-2","article-title":"Histone editing elucidates the functional roles of H3K27 methylation and acetylation in mammals","volume":"54","author":"Sankar","year":"2022","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.bneo.2024.100059_bib76","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13059-020-01957-w","article-title":"Histone H3K27 acetylation is dispensable for enhancer activity in mouse embryonic stem cells","volume":"21","author":"Zhang","year":"2020","journal-title":"Genome Biol"},{"issue":"3","key":"10.1016\/j.bneo.2024.100059_bib77","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1172\/JCI23409","article-title":"In\u00a0vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells","volume":"115","author":"Messmer","year":"2005","journal-title":"J\u00a0Clin Investig"},{"issue":"2","key":"10.1016\/j.bneo.2024.100059_bib78","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1365-2141.2008.07348.x","article-title":"Reduction of B cell turnover in chronic lymphocytic leukaemia","volume":"143","author":"Defoiche","year":"2008","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1016\/j.bneo.2024.100059_bib79","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41576-020-00312-w","article-title":"Parental nucleosome segregation and the inheritance of cellular identity","volume":"22","author":"Escobar","year":"2021","journal-title":"Nat Rev Genet"},{"issue":"4","key":"10.1016\/j.bneo.2024.100059_bib80","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.cell.2019.10.009","article-title":"Active and repressed chromatin domains exhibit distinct nucleosome segregation during DNA replication","volume":"179","author":"Escobar","year":"2019","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.bneo.2024.100059_bib81","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.tibs.2023.02.007","article-title":"Diverse heterochromatin states restricting cell identity and reprogramming","volume":"48","author":"McCarthy","year":"2023","journal-title":"Trends Biochem Sci"}],"container-title":["Blood Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950328024000591?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950328024000591?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T22:41:38Z","timestamp":1772923298000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950328024000591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":80,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S2950328024000591"],"URL":"https:\/\/doi.org\/10.1016\/j.bneo.2024.100059","relation":{},"ISSN":["2950-3280"],"issn-type":[{"value":"2950-3280","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aberrant heterochromatin silences immune response genes in chronic lymphocytic leukemia","name":"articletitle","label":"Article Title"},{"value":"Blood Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bneo.2024.100059","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society of Hematology. Published by Elsevier Inc. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100059"}}